This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...